Source: Blood [Blood] 2023 Apr 06; Vol. 141 (14), pp. 1675-1684.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2.

Authors : Savage KJ; Centre for Lymphoid Cancer and Division of Medical Oncology, British Columbia Cancer, Vancouver, BC, Canada.; Horwitz SM

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphoma, Large-Cell, Anaplastic*/Lymphoma, Large-Cell, Anaplastic*/Lymphoma, Large-Cell, Anaplastic*/chemically induced ; Lymphoma, Large-Cell, Anaplastic*/Lymphoma, Large-Cell, Anaplastic*/Lymphoma, Large-Cell, Anaplastic*/therapy

Source: Blood advances [Blood Adv] 2022 Oct 11; Vol. 6 (19), pp. 5550-5555.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.

Authors : Kamdar M; Solomon SR ...

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Thrombocytopenia*/Thrombocytopenia*/Thrombocytopenia*/drug therapy

Source: Lancet (London, England) [Lancet] 2022 Jun 18; Vol. 399 (10343), pp. 2294-2308.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.

Authors : Schenone L; Houillier C ...

Subjects: Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/drug therapy ; Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/pathology ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects

Source: Bone marrow transplantation [Bone Marrow Transplant] 2022 Jun; Vol. 57 (6), pp. 966-974. Date of Electronic Publication: 2022 Apr 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.

Authors : Bishop MR; From the David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago (M.R.B.); Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC (M. Dickinson), Fiona Stanley Hospital, Murdoch, WA (D.P.), and the Department of Haematology, St. Vincent's Hospital Sydney, and St. Vincent's Clinical School, University of New South Wales, Sydney (N.H.) - all in Australia

Subjects: Hematopoietic Stem Cell Transplantation* ; Immunotherapy, Adoptive*; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use

Source: The New England journal of medicine [N Engl J Med] 2022 Feb 17; Vol. 386 (7), pp. 629-639. Date of Electronic Publication: 2021 Dec 14.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.

Authors : Nerich V; Department of Pharmacy, University Hospital, Besançon, France.; INSERM, EFS-BFC, UMR1098, University of Franche-Comté, Besançon, France.

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphoma* ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/therapy

Source: Cancer [Cancer] 2022 Feb 01; Vol. 128 (3), pp. 519-528. Date of Electronic Publication: 2021 Oct 04.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.

Authors : Mounier N; Onco-Hematology Unit, l'Archet Hospital, Nice University Hospital Center, University of Côte d'Azur, Nice, France.; Anthony S

Subjects: Quality of Life*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*adverse effects ; Cancer Survivors/Cancer Survivors/Cancer Survivors/*statistics & numerical data

Source: Cancer [Cancer] 2019 Jul 01; Vol. 125 (13), pp. 2291-2299. Date of Electronic Publication: 2019 Mar 22.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

Authors : Le Gouill S; LYSA Group

Subjects: Hematopoietic Stem Cell Transplantation*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Immunologic Factors/Immunologic Factors/Immunologic Factors/*administration & dosage DHAP protocol

Source: The New England journal of medicine [N Engl J Med] 2017 Sep 28; Vol. 377 (13), pp. 1250-1260.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma.

Authors : Herbaux C; Centre Hospitalier Universitaire (CHU) Lille, Service des Maladies du Sang, Lille, France.; Gauthier J

Subjects: Hematopoietic Stem Cell Transplantation*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*administration & dosage ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy

Source: Blood [Blood] 2017 May 04; Vol. 129 (18), pp. 2471-2478. Date of Electronic Publication: 2017 Mar 07.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Report

Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.

Authors : von Tresckow B; a Department of Internal Medicine I, German Hodgkin Study Group (GHSG) , University Hospital of Cologne , Kerpener Str. 62 , Cologne , Germany.; Morschhauser F

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/Hematopoietic Stem Cell Transplantation/*methods ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*therapy

Source: Leukemia & lymphoma [Leuk Lymphoma] 2017 Jan; Vol. 58 (1), pp. 222-225. Date of Electronic Publication: 2016 May 17.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي